Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings

Lisa A de Jong, Jessie Groeneveld, Jelena Stevanovic, Harrie Rila, Robert G Tieleman, Menno V Huisman, Maarten J Postma, Marinus van Hulst

Research output: Contribution to journalErratumAcademic

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0222658.].

Original languageEnglish
Article numbere0266625
Number of pages5
JournalPLoS ONE
Volume17
Issue number3
DOIs
Publication statusPublished - 31-Mar-2022

Cite this